{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:14:49Z","timestamp":1783473289493,"version":"3.55.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006109","name":"Scientific Grant Agency of the M\u0160VVa\u0160 and the SAV","doi-asserted-by":"publisher","award":["1\/0385\/25"],"award-info":[{"award-number":["1\/0385\/25"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bmc.2026.118601","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T16:14:24Z","timestamp":1771172064000},"page":"118601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Kynurenic acid derivatives in treatment for Alzheimer's disease"],"prefix":"10.1016","volume":"136","author":[{"given":"Branislav","family":"Pavilek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Hajduov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du\u0161an","family":"Bort\u0148\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Milata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bmc.2026.118601_bb0005","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 lzheimer\u2019s disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.bmc.2026.118601_bb0010","first-page":"550","article-title":"Dementia and neurodegenerative diseases: what is known and what is promising at the cellular and molecular level","volume":"135","author":"Moroz","year":"2024","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"S18","key":"10.1016\/j.bmc.2026.118601_bb0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1017\/S1092852900014164","article-title":"The interplay of neurotransmitters in Alzheimer\u2019s disease","volume":"10","author":"Francis","year":"2005","journal-title":"CNS Spectrums"},{"issue":"5054","key":"10.1016\/j.bmc.2026.118601_bb0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid Cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bmc.2026.118601_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.bmc.2026.118601_bb0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"The Journal of Prevention of Alzheimer\u2019s Disease"},{"issue":"6","key":"10.1016\/j.bmc.2026.118601_bb0035","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"8019","key":"10.1016\/j.bmc.2026.118601_bb0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41586-024-07691-8","article-title":"Retraction note: a specific amyloid-\u03b2 protein assembly in the brain impairs memory","volume":"631","author":"Lesn\u00e9","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2026.118601_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s disease","volume":"12","author":"Kametani","year":"2018","journal-title":"Front Neurosci"},{"issue":"12","key":"10.1016\/j.bmc.2026.118601_bb0050","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","article-title":"Tau-targeting therapies for Alzheimer disease: current status and future directions","volume":"19","author":"Congdon","year":"2023","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.bmc.2026.118601_bb0055","article-title":"Adult hippocampal neurogenesis in Alzheimer\u2019s disease: an overview of human and animal studies with implications for therapeutic perspectives aimed at memory recovery","volume":"2022","author":"Farioli-Vecchioli","year":"2022","journal-title":"Neural Plasticity"},{"issue":"1","key":"10.1016\/j.bmc.2026.118601_bb0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1602\/neurorx.1.1.117","article-title":"Neuroprotective strategies in Alzheimer\u2019s disease","volume":"1","author":"Longo","year":"2004","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.bmc.2026.118601_bb0065","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"The Lancet Neurology"},{"issue":"5","key":"10.1016\/j.bmc.2026.118601_bb0070","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/br.2016.630","article-title":"Role of oxidative stress in Alzheimer\u2019s disease (review)","volume":"4","author":"Huang","year":"2016","journal-title":"Biomedical Reports"},{"issue":"3","key":"10.1016\/j.bmc.2026.118601_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2527","article-title":"Effect of metal ions on Alzheimer\u2019s disease","volume":"12","author":"Liu","year":"2022","journal-title":"Brain Behav"},{"issue":"12","key":"10.1016\/j.bmc.2026.118601_bb0080","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jsps.2022.10.004","article-title":"An update on the novel and approved drugs for Alzheimer disease","volume":"30","author":"Alhazmi","year":"2022","journal-title":"Saudi Pharm J"},{"issue":"9","key":"10.1016\/j.bmc.2026.118601_bb0085","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneurol.2016.120","article-title":"Phase III trial of anti-tau drug generates mixed messages","volume":"12","author":"Wood","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"10.1016\/j.bmc.2026.118601_bb0090","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamaneurol.2022.1375","article-title":"Safety and efficacy of Semorinemab in individuals with prodromal to mild Alzheimer disease: a randomized clinical trial","volume":"79","author":"Teng","year":"2022","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.1016\/j.bmc.2026.118601_bb0095","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s43587-023-00523-w","article-title":"TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer\u2019s disease","volume":"3","author":"Shulman","year":"2023","journal-title":"Nat Aging"},{"issue":"6","key":"10.1016\/j.bmc.2026.118601_bb0100","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","article-title":"Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer\u2019s disease: a phase 1b, randomized, placebo-controlled trial","volume":"29","author":"Mummery","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.bmc.2026.118601_bb0105","article-title":"Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer\u2019s disease","volume":"7","author":"Potter","year":"2021","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions"},{"issue":"1","key":"10.1016\/j.bmc.2026.118601_bb0110","article-title":"A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer\u2019s disease therapy: analysis of the blarcamesine (ANAVEX2-73) phase 2a clinical study","volume":"6","author":"Hampel","year":"2020","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions"},{"issue":"18","key":"10.1016\/j.bmc.2026.118601_bb0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/ijms241813927","article-title":"Simufilam reverses aberrant receptor interactions of filamin a in Alzheimer\u2019s disease","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1016\/j.bmc.2026.118601_bb0120","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid inhibits \u03b17 nicotinic receptor activity and increases non-\u03b17 nicotinic receptor expression: Physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J Neurosci"},{"issue":"16","key":"10.1016\/j.bmc.2026.118601_bb0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/ijms25169040","article-title":"The complex world of kynurenic acid: reflections on biological issues and therapeutic strategy","volume":"25","author":"Stone","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.bmc.2026.118601_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/metabo15030210","article-title":"Diverse physiological roles of kynurenine pathway metabolites: updated implications for health and disease","volume":"15","author":"Wang","year":"2025","journal-title":"Metabolites"},{"key":"10.1016\/j.bmc.2026.118601_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fspor.2025.1535152","article-title":"Exercise-induced adaptations in the kynurenine pathway: implications for health and disease management","volume":"7","author":"Rangel","year":"2025","journal-title":"Front Sports Act Living"},{"issue":"1","key":"10.1016\/j.bmc.2026.118601_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom15010074","article-title":"Importance of modulating kynurenic acid metabolism\u2014approaches for the treatment of dementia","volume":"15","author":"Baran","year":"2025","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.bmc.2026.118601_bb0145","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1002\/alz.13162","article-title":"Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer\u2019s disease","volume":"19","author":"Knapskog","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.bmc.2026.118601_bb0150","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.bmc.2026.118601_bb0155","doi-asserted-by":"crossref","first-page":"20907","DOI":"10.1021\/acsomega.5c02339","article-title":"Fabrication of MIP-based sensors for femtomolar detection of kynurenic acid for early diagnosis of neurodegenerative diseases","volume":"10","author":"Turan","year":"2025","journal-title":"ACS Omega"},{"issue":"8","key":"10.1016\/j.bmc.2026.118601_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2002032","article-title":"The beneficial effects of dietary restriction on learning are distinct from its effects on longevity and mediated by depletion of a neuroinhibitory metabolite","volume":"15","author":"Vohra","year":"2017","journal-title":"PLoS Biol"},{"key":"10.1016\/j.bmc.2026.118601_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115168","article-title":"Evaluation of solubility enhancement, antioxidant activity, and cytotoxicity studies of kynurenic acid loaded cyclodextrin nanosponge","volume":"224","author":"Dhakar","year":"2019","journal-title":"Carbohydr Polym"},{"issue":"6","key":"10.1016\/j.bmc.2026.118601_bb0170","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood\u2013brain barrier transport of kynurenines: implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2026.118601_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103291","article-title":"Recent advances in the synthetic and medicinal perspective of quinolones: a review","volume":"92","author":"Dhiman","year":"2019","journal-title":"Bioorg Chem"},{"issue":"1","key":"10.1016\/j.bmc.2026.118601_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules30010163","article-title":"Quinolin-4-ones: methods of synthesis and application in medicine","volume":"30","author":"Gach-Janczak","year":"2025","journal-title":"Molecules"},{"issue":"15","key":"10.1016\/j.bmc.2026.118601_bb0185","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1021\/acs.joc.3c00446","article-title":"Convenient one-pot synthesis of kynurenic acid ethyl Ester and Exploration to direct synthesis of neuroprotective kynurenic acid and amide derivatives","volume":"88","author":"Verma","year":"2023","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.bmc.2026.118601_bb0190","series-title":"Development of antibacterial agents of the nalidixic acid type. In: Jucker E, ed. Progress in Drug Research \/ Fortschritte Der Arzneimittelforschung \/ Progr\u00e8s Des Rechersches Pharmaceutiques","first-page":"9","author":"Albrecht","year":"1977"},{"issue":"22","key":"10.1016\/j.bmc.2026.118601_bb0195","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/j.bmcl.2018.09.037","article-title":"Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors","volume":"28","author":"Fang","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"10.1016\/j.bmc.2026.118601_bb0200","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1021\/jacs.0c12128","article-title":"Foldamer-based potassium channels with high ion selectivity and transport activity","volume":"143","author":"Qi","year":"2021","journal-title":"J Am Chem Soc"},{"issue":"11","key":"10.1016\/j.bmc.2026.118601_bb0205","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/jlac.197619761105","article-title":"Verfahren zur Darstellung von 4-Oxo-1,4-dihydropyridincarbons\u00e4urederivaten","volume":"1976","author":"Biere","year":"1976","journal-title":"Justus Liebigs Annalen der Chemie"},{"issue":"03","key":"10.1016\/j.bmc.2026.118601_bb0210","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1055\/s-0031-1290079","article-title":"Synthetic protocols mutually applicable to 4-oxoquinolines and 4-oxo-1,8-naphthyridines: synthesis of 1-aryl-2-substituted and 1-aryl-3-fluoro-4-oxoquinolines and 4-oxo-1,8-naphthyridines","volume":"2012","author":"Awasaguchi","year":"2012","journal-title":"Synlett"},{"key":"10.1016\/j.bmc.2026.118601_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2024.126621","article-title":"Unravelling the mechanism of f-element extraction by phenanthroline-diamides: a case of 4,7-substituted 1,10-phenanthroline-2,9-diamides","volume":"339","author":"Evsiunina","year":"2024","journal-title":"Sep Purif Technol"},{"issue":"46","key":"10.1016\/j.bmc.2026.118601_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/ejoc.202300894","article-title":"Synthesis of highly substituted Pyrrolo[1,2-a]quinoline-3,5-diones through ag(I) catalyzed cyclization of 4-Hydroxyquinolinyl-2-ynones","volume":"26","author":"Kurian","year":"2023","journal-title":"Eur J Org Chem"},{"issue":"18","key":"10.1016\/j.bmc.2026.118601_bb0225","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1021\/acs.orglett.7b02495","article-title":"Direct synthesis of 4-quinolones via copper-catalyzed anilines and alkynes","volume":"19","author":"Xu","year":"2017","journal-title":"Org Lett"},{"issue":"20","key":"10.1016\/j.bmc.2026.118601_bb0230","doi-asserted-by":"crossref","first-page":"17966","DOI":"10.1021\/acsomega.3c01170","article-title":"Novel eco-friendly, one-pot method for the synthesis of kynurenic acid ethyl esters","volume":"8","author":"Simon","year":"2023","journal-title":"ACS Omega"},{"issue":"7","key":"10.1016\/j.bmc.2026.118601_bb0235","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.tetlet.2011.11.125","article-title":"Highly efficient thermal cyclization reactions of alkylidene esters in continuous flow to give aromatic\/heteroaromatic derivatives","volume":"53","author":"Lengyel","year":"2012","journal-title":"Tetrahedron Lett"},{"issue":"32","key":"10.1016\/j.bmc.2026.118601_bb0240","doi-asserted-by":"crossref","first-page":"26420","DOI":"10.1039\/D5RA04301H","article-title":"Selective heterofunctionalization of kynurenic acid derivatives","volume":"15","author":"T\u00f6rteli","year":"2025","journal-title":"RSC Adv"},{"issue":"6","key":"10.1016\/j.bmc.2026.118601_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063394","article-title":"The impact of C-3 side chain modifications on kynurenic acid: a Behavioral analysis of its Analogs in the motor domain","volume":"25","author":"Martos","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"21","key":"10.1016\/j.bmc.2026.118601_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111935","article-title":"Kyna derivatives with modified skeleton; hydroxyquinolines with potential neuroprotective effect","volume":"22","author":"L\u0151rinczi","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.bmc.2026.118601_bb0255","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1021\/acschemneuro.7b00229","article-title":"Multifunctional analogs of kynurenic acid for the treatment of Alzheimer\u2019s disease: synthesis, pharmacology, and molecular modeling studies","volume":"8","author":"Deora","year":"2017","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"10.1016\/j.bmc.2026.118601_bb0260","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bmcl.2007.10.097","article-title":"Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors","volume":"18","author":"Nam","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"10.1016\/j.bmc.2026.118601_bb0265","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1527-3458.2006.00135.x","article-title":"Involvement of calpain activation in neurodegenerative processes","volume":"12","author":"Camins","year":"2006","journal-title":"CNS Drug Reviews"},{"issue":"2","key":"10.1016\/j.bmc.2026.118601_bb0270","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ajpath.2012.04.020","article-title":"Calpain inhibitor A-705253 mitigates Alzheimer\u2019s disease\u2013like pathology and cognitive decline in aged 3xTgAD mice","volume":"181","author":"Medeiros","year":"2012","journal-title":"Am J Pathol"},{"issue":"47","key":"10.1016\/j.bmc.2026.118601_bb0275","doi-asserted-by":"crossref","first-page":"17098","DOI":"10.1021\/jacs.7b08259","article-title":"Foldamer-mediated structural rearrangement attenuates a\u03b2 oligomerization and cytotoxicity","volume":"139","author":"Kumar","year":"2017","journal-title":"J Am Chem Soc"},{"issue":"7","key":"10.1016\/j.bmc.2026.118601_bb0280","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1021\/acschemneuro.4c00753","article-title":"A brain-penetrating foldamer rescues a\u03b2 aggregation-associated Alzheimer\u2019s disease phenotypes in in vivo models","volume":"16","author":"Baysah","year":"2025","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"10.1016\/j.bmc.2026.118601_bb0285","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1080\/14756366.2019.1581184","article-title":"New flavonoid \u2013 N,N-dibenzyl(N-methyl)amine hybrids: multi-target-directed agents for Alzheimer\u2019s disease endowed with neurogenic properties","volume":"34","author":"Estrada-Valencia","year":"2019","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2026.118601_bb0290","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ejmech.2018.07.026","article-title":"Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer\u2019s disease","volume":"156","author":"Estrada-Valencia","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"17","key":"10.1016\/j.bmc.2026.118601_bb0295","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1021\/jm070100g","article-title":"Extensive SAR and computational studies of 3-{4-[(Benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives","volume":"50","author":"Piazzi","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118601_bb0300","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ejmech.2018.07.033","article-title":"Multi-target-directed ligands for treating Alzheimer\u2019s disease: butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities","volume":"156","author":"Knez","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2026.118601_bb0305","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-2236(03)00067-5","article-title":"The metallobiology of Alzheimer\u2019s disease","volume":"26","author":"Bush","year":"2003","journal-title":"Trends Neurosci"},{"issue":"14","key":"10.1016\/j.bmc.2026.118601_bb0310","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1074\/jbc.M111.309070","article-title":"Synaptic released zinc promotes tau hyperphosphorylation by inhibition of protein phosphatase 2A (PP2A)*","volume":"287","author":"Sun","year":"2012","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/j.bmc.2026.118601_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24234217","article-title":"Discovery of selective butyrylcholinesterase (BChE) inhibitors through a combination of computational studies and biological evaluations","volume":"24","author":"Zhou","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bmc.2026.118601_bb0320","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-3565(24)35280-2","article-title":"Novel structure having antagonist actions at both the Glycine site of the N-methyl\u2011d-aspartate receptor and neuronal voltage-sensitive sodium channels: biochemical, electrophysiological, and behavioral characterization1","volume":"292","author":"Snell","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.bmc.2026.118601_bb0325","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/life13081655","article-title":"Voltage-gated Na+ channels in Alzheimer\u2019s disease: physiological roles and therapeutic potential","volume":"13","author":"Baumgartner","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.bmc.2026.118601_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2025.138220","article-title":"Age-dependent changes in NMDA-induced excitotoxicity and neuromodulatory effects of kynurenic acid and its analogue in mouse brain slices","volume":"854","author":"Balog","year":"2025","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bmc.2026.118601_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112935","article-title":"Increased blood-brain barrier permeability of neuroprotective drug by colloidal serum albumin carriers","volume":"220","author":"Hornok","year":"2022","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"2","key":"10.1016\/j.bmc.2026.118601_bb0340","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.bmc.2026.118601_bb0345","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2026.118601_bb0350","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijpharm.2004.10.007","article-title":"Evaluation of the MDR-MDCK cell line as a permeability screen for the blood\u2013brain barrier","volume":"288","author":"Wang","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.bmc.2026.118601_bb0355","series-title":"Drug-like Properties: Concept, Structure Design and Methods, from ADME to Toxicity Optimization","author":"Kerns","year":"2008"},{"issue":"2","key":"10.1016\/j.bmc.2026.118601_bb0360","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1021\/acs.molpharmaceut.3c00700","article-title":"Role of transporters and enzymes in metabolism and distribution of 4-Chlorokynurenine (AV-101)","volume":"21","author":"Patel","year":"2024","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmc.2026.118601_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.insi.2025.100049","article-title":"Artificial intelligence (AI) in drug design and discovery: a comprehensive review","volume":"1","author":"Bhat","year":"2025","journal-title":"In Silico Research in Biomedicine"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962600057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962600057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T08:59:46Z","timestamp":1776157186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096808962600057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":73,"alternative-id":["S096808962600057X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118601","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kynurenic acid derivatives in treatment for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118601"}}